BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20053825)

  • 1. Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.
    Herd KA; Nelson M; Mahalingam S; Tindle RW
    J Gen Virol; 2010 May; 91(Pt 5):1302-10. PubMed ID: 20053825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice.
    Herd KA; Mahalingam S; Mackay IM; Nissen M; Sloots TP; Tindle RW
    J Virol; 2006 Feb; 80(4):2034-44. PubMed ID: 16439559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
    Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
    J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response and alteration of pulmonary function after primary human metapneumovirus (hMPV) infection of BALB/c mice.
    Darniot M; Petrella T; Aho S; Pothier P; Manoha C
    Vaccine; 2005 Aug; 23(36):4473-80. PubMed ID: 15927322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease.
    Herd KA; Nissen MD; Hopkins PM; Sloots TP; Tindle RW
    J Infect Dis; 2008 Feb; 197(4):584-92. PubMed ID: 18240952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children.
    Mbawuike IN; Wells J; Byrd R; Cron SG; Glezen WP; Piedra PA
    J Infect Dis; 2001 Mar; 183(5):687-96. PubMed ID: 11181144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with a recombinant bacillus Calmette-Guerin strain confers protective Th1 immunity against the human metapneumovirus.
    Palavecino CE; Céspedes PF; Gómez RS; Kalergis AM; Bueno SM
    J Immunol; 2014 Jan; 192(1):214-23. PubMed ID: 24319265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus.
    Ebihara T; Endo R; Kikuta H; Ishiguro N; Ishiko H; Kobayashi K
    J Med Virol; 2004 Feb; 72(2):304-6. PubMed ID: 14695674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice.
    Alvarez R; Tripp RA
    J Virol; 2005 May; 79(10):5971-8. PubMed ID: 15857983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
    Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
    Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human metapneumovirus induces more severe disease and stronger innate immune response in BALB/c mice as compared with respiratory syncytial virus.
    Huck B; Neumann-Haefelin D; Schmitt-Graeff A; Weckmann M; Mattes J; Ehl S; Falcone V
    Respir Res; 2007 Jan; 8(1):6. PubMed ID: 17257445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TH(1)- and TH(2)-TYPE cytokine expression by activated t lymphocytes from the lung and spleen during the inflammatory response to respiratory syncytial virus.
    Tripp RA; Moore D; Anderson LJ
    Cytokine; 2000 Jun; 12(6):801-7. PubMed ID: 10843768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distinguishing features of human metapneumovirus and respiratory syncytial virus.
    Papenburg J; Boivin G
    Rev Med Virol; 2010 Jul; 20(4):245-60. PubMed ID: 20586081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tetrabromobisphenol A, a brominated flame retardant, on the immune response to respiratory syncytial virus infection in mice.
    Watanabe W; Shimizu T; Sawamura R; Hino A; Konno K; Hirose A; Kurokawa M
    Int Immunopharmacol; 2010 Apr; 10(4):393-7. PubMed ID: 20074668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy.
    Laham FR; Israele V; Casellas JM; Garcia AM; Lac Prugent CM; Hoffman SJ; Hauer D; Thumar B; Name MI; Pascual A; Taratutto N; Ishida MT; Balduzzi M; Maccarone M; Jackli S; Passarino R; Gaivironsky RA; Karron RA; Polack NR; Polack FP
    J Infect Dis; 2004 Jun; 189(11):2047-56. PubMed ID: 15143472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate local and systemic respiratory syncytial virus-specific T-cell responses upon mild or subclinical RSV infection.
    de Waal L; Koopman LP; van Benten IJ; Brandenburg AH; Mulder PG; de Swart RL; Fokkens WJ; Neijens HJ; Osterhaus AD
    J Med Virol; 2003 Jun; 70(2):309-18. PubMed ID: 12696123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma.
    Ostler T; Davidson W; Ehl S
    Eur J Immunol; 2002 Aug; 32(8):2117-23. PubMed ID: 12209623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4(+) T cell frequencies and Th1/Th2 cytokine patterns expressed in the acute and memory response to respiratory syncytial virus I-E(d)-restricted peptides.
    Tripp RA; Hou S; Etchart N; Prinz A; Moore D; Winter J; Anderson LJ
    Cell Immunol; 2001 Jan; 207(1):59-71. PubMed ID: 11161454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.